InvestorsHub Logo
Followers 11
Posts 1187
Boards Moderated 0
Alias Born 10/16/2007

Re: None

Thursday, 11/17/2011 1:43:49 PM

Thursday, November 17, 2011 1:43:49 PM

Post# of 48225
Never saw a PR for this...
http://allezoe.com/News/PR/Allezoe-Medical-Holdings-To-Review-Recent-Trading-Activity

Allezoe Medical Holdings To Review Recent Trading Activity

(OTCBB:ALZM) announced that it has initiated an internal review and investigation of the unusually high volume of trading in its common shares on the OTC Bulletin Board, and the resulting precipitous drop in the market price for the stock. CEO Michael Gelmon says, “It appears that the high volume of selling has now abated and that the market activity has returned to more normal levels, but we are inquiring into this unusual trading pattern.”

Preliminary indications are that the trading in question was conducted by an unidentified group of shareholders, who may be affiliated or working in concert, and who have been selling a large block of shares they obtained and held before the recent (February, 2011) change in control and business direction of the company occurred. The trading did not involve any shares held by Allezoe’s officers, directors or other insiders, as those shares were all obtained at or shortly after the change in control and termination of the Company’s status as a shell company last February (under Rule 144, their shares are all restricted from trading until after one year from February 2011)

It further appears that the group of shareholders in question has been trading their stock through a securities brokerage firm based in The Bahamas, which has been placing the sales though a US brokerage firm based in Scottsdale Arizona.

Allezoe CEO Michael Gelmon says, “We are concerned that a large block of common stock of Allezoe Medical, well in excess of ten percent of the shares outstanding, has been sold into the market in the past thirty days without regard to any volume limits, through a common source. The result has been to drop the market price of the stock significantly, to the detriment of our other, un-affiliated, shareholders. We are always committed to acting in the best interests of our shareholders, and will review this trading activity in the hopes of learning how we can prevent it from ever happening again.”

About Allezoe Medical Holdings
Allezoe Medical Holdings, Inc. (OTCBB: ALZM) is a holding company focused on acquiring the most high-quality and in demand medical products, solutions and services. Whether through diagnosis, treatment, or medical research itself, Allezoe is interested in companies that are making a striking difference in the healthcare system through technology and treatments for health issues that affect large populations. For more information, please visit www.allezoe.com.

Safe Harbor Statement

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risk that could cause actual performance and results of operations to differ materially from those anticipated. These risks are set forth in the Company's most recently filed form 10-K and Form 10-Q reports. The Company assumes no obligation to update the statements contained in this release except as required by applicable securities disclosure rules. The Company's SEC filings are available at http://www.sec.gov.

"A pessimist is an optimist with experience."
Mark Twain